Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Update on the role of noncoding RNAs in vitiligo. | Chin Med J (Engl) | 2022 | 34935694 | PubTator, text mining | PubMed |
| A Deep-Learning Approach for Inference of Selective Sweeps from the Ancestral Recombination Graph. | Mol Biol Evol | 2022 | 34888675 | PubTator, text mining | PubMed |
| Tranexamic acid inhibits melanogenesis partially via stimulation of TGF-β1 expression in human epidermal keratinocytes. | Exp Dermatol | 2022 | 34862827 | PubTator, text mining | PubMed |
| LncRNA-mRNA co-expression network revealing the regulatory roles of lncRNAs in melanogenesis in vitiligo. | J Hum Genet | 2022 | 34815525 | PubTator, text mining | PubMed |
| Comparative study of the photo‑protective and anti‑melanogenic properties of gomisin D, J and O. | Mol Med Rep | 2022 | 34751410 | PubTator, text mining | PubMed |
| Advances in integrative African genomics. | Trends Genet | 2022 | 34740451 | PubTator, text mining | PubMed |
| Melanogenesis Markers Expression in Premature Graying of Hair: A Cross-Sectional Study. | Skin Pharmacol Physiol | 2022 | 34700322 | PubTator, text mining | PubMed |
| The mucin protein MUCL1 regulates melanogenesis and melanoma genes in a manner dependent on threonine content. | Br J Dermatol | 2022 | 34545566 | PubTator, text mining | PubMed |
| Phenotypic plasticity of melanocytes derived from human adult skin. | Pigment Cell Melanoma Res | 2022 | 34467641 | PubTator, text mining | PubMed |
| What colour are your eyes? Teaching the genetics of eye colour & colour vision. Edridge Green Lecture RCOphth Annual Congress Glasgow May 2019. | Eye (Lond) | 2022 | 34426658 | PubTator, text mining | PubMed |
| Blue Lagoon Algae Improve Uneven Skin Pigmentation: Results from in vitro Studies and from a Monocentric, Randomized, Double-Blind, Vehicle-Controlled, Split-Face Study. | Skin Pharmacol Physiol | 2022 | 34348349 | PubTator, text mining | PubMed |
| Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study. | Eur Respir J | 2022 | 34172473 | PubTator, text mining | PubMed |
An open-label, investigator-initiated, single-center, prospective, pilot clinical study to evaluate the efficacy of a skin whitening serum applied twice daily combined with a spot-preventing SPF50+ sunscreen in healthy female subjects with melasma hyperpigmentation. | J Cosmet Dermatol | 2022 | 34087055 | PubTator, text mining | PubMed |
| Impact of acute inflammation on Band 3 protein anion exchange capability in human erythrocytes. | Arch Physiol Biochem | 2022 | 32401056 | PubTator, text mining | PubMed |
| Sorafenib induces pigmentation via the regulation of β-catenin signalling pathway in melanoma cells. | Exp Dermatol | 2022 | 32391926 | PubTator, text mining | PubMed |
| Melanin production by Pseudomonas sp. and in silico comparative analysis of tyrosinase gene sequences. | BioTechnologia (Pozn) | 2021 | 36605604 | PubTator, text mining | PubMed |
| Daphnane-type diterpenes from genus Daphne and their anti-tumor activity. | Chin Herb Med | 2021 | 36117500 | PubTator, text mining | PubMed |
| The bioactivities of resveratrol and its naturally occurring derivatives on skin. | J Food Drug Anal | 2021 | 35696226 | PubTator, text mining | PubMed |
| Human Proteinase 3, an important autoantigen of c-ANCA associated vasculitis, shares cross-reactive epitopes with serine protease allergens from mites: an in silico analysis. | F1000Res | 2021 | 35602671 | PubTator, text mining | PubMed |
| Natural and synthetic flavonoid derivatives as new potential tyrosinase inhibitors: a systematic review. | RSC Adv | 2021 | 35480807 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=39